These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30766845)

  • 1. Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters.
    Dhande AN; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Pandya N; Mohanapure N; Aggarwal A; Patil G
    South Asian J Cancer; 2019; 8(1):18-21. PubMed ID: 30766845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of Vimentin in Invasive Breast Carcinoma and Its Correlation with Clinicopathological Parameters.
    Khillare CD; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Gogate BP; Battin S
    Niger Med J; 2019; 60(1):17-21. PubMed ID: 31413430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67.
    Puri V; Jain M; Thomas S
    Int J Breast Cancer; 2011; 2011():437957. PubMed ID: 22295223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.
    Jana SH; Jha BM; Patel C; Jana D; Agarwal A
    Indian J Pathol Microbiol; 2014; 57(4):530-6. PubMed ID: 25308002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
    Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
    Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
    Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal expression of CD10 in invasive breast carcinoma and its association with tumour stage, grade, ER, PR and HER2 status.
    Kamarudin NA; Abd Shukor N; Farouk WI; Muhammad Hanapi NA; Mohammed F
    Malays J Pathol; 2021 Dec; 43(3):389-396. PubMed ID: 34958060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
    Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
    Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal Expression of CD10 in Breast Carcinoma and Its Association with Known Prognostic Factors-A Tissue Microarray-Based Study.
    Gaffoor N; Krishnamurthy J
    J Lab Physicians; 2023 Sep; 15(3):354-360. PubMed ID: 37564218
    [No Abstract]   [Full Text] [Related]  

  • 10. The Prognostic Significance of CD10 Expression in Invasive Breast Carcinoma in Tunisian Patients.
    Makni S; Mellouli M; Saguem I; Boudawara O; Gouiaa N; Boudawara TS; Feki J; Kallel R
    Gulf J Oncolog; 2022 Sep; 1(40):15-23. PubMed ID: 36448066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use.
    Chand P; Garg A; Singla V; Rani N
    Niger J Surg; 2018; 24(2):100-106. PubMed ID: 30283220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
    Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
    Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-Box binding protein 1 expression in breast cancer and its correlation with hormone receptors and other prognostic markers.
    Bansal T; Tanveer N; Singh UR; Sharma S; Kaur N
    J Lab Physicians; 2018; 10(4):420-425. PubMed ID: 30498315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.
    Kondov B; Kondov G; Spirovski Z; Milenkovikj Z; Colanceski R; Petrusevska G; Pesevska M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):81-90. PubMed ID: 28593885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
    Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
    Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
    Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of CD10 positivity of stromal cells in core needle biopsy specimen of breast cancer patients and its relation with histological grade and lymphovascular invasion.
    Boler AK; Akhtar S; Bandyopadhyay A; Bandyopadhyay G
    Indian J Pathol Microbiol; 2021; 64(3):460-463. PubMed ID: 34341253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
    Louhichi T; Saad H; Dhiab MB; Ziadi S; Trimeche M
    BMC Cancer; 2018 Jan; 18(1):49. PubMed ID: 29306324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.